Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Callebaut

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Research in Virology|January 1, 1996
CD26 and HIV infectionC Callebaut, A G Hovanessian
AIDS Research and Human Retroviruses|November 1, 1993
Inhibition of entry of HIV into cells by poly(A).poly(U)B Krust, C Callebaut, A G Hovanessian
Science (New York, N.Y.)|May 20, 1994
ResponseC Callebaut, E Jacotot, B Krust, et al.
Science (New York, N.Y.)|December 24, 1993
T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cellsC Callebaut, B Krust, E Jacotot, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Further characterization of DPP IV-beta, a novel cell surface expressed protein with dipeptidyl peptidase activityJ Blanco, E Jacotot, C Callebaut, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 22, 2018
Measurement of plasma HIV-1 RNA below the limit of quantification (<20 copies/mL) of commercial assays with the integrase HIV RNA single-copy assayN Margot, D Koontz, S McCallister, et al.
Experimental Cell Research|June 25, 1998
Increased rate of HIV-1 entry and its cytopathic effect in CD4+/CXCR4+ T cells expressing relatively high levels of CD26C Callebaut, E Jacotot, J Blanco, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
The level of CD26 determines the rate of HIV entry in a CD4+ T-cell lineC Callebaut, E Jacotot, J Blanco, et al.
Virology|March 30, 2001
Inhibition of HIV infection by the cytokine midkineC Callebaut, S Nisole, J P Briand, et al.
Journal of Virology|April 25, 2000
CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcriptionS Le Borgne, M Février, C Callebaut, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Research in Virology|January 1, 1996
CD26 and HIV infectionC Callebaut, A G Hovanessian
AIDS Research and Human Retroviruses|November 1, 1993
Inhibition of entry of HIV into cells by poly(A).poly(U)B Krust, C Callebaut, A G Hovanessian
Science (New York, N.Y.)|May 20, 1994
ResponseC Callebaut, E Jacotot, B Krust, et al.
Science (New York, N.Y.)|December 24, 1993
T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cellsC Callebaut, B Krust, E Jacotot, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Further characterization of DPP IV-beta, a novel cell surface expressed protein with dipeptidyl peptidase activityJ Blanco, E Jacotot, C Callebaut, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 22, 2018
Measurement of plasma HIV-1 RNA below the limit of quantification (<20 copies/mL) of commercial assays with the integrase HIV RNA single-copy assayN Margot, D Koontz, S McCallister, et al.
Experimental Cell Research|June 25, 1998
Increased rate of HIV-1 entry and its cytopathic effect in CD4+/CXCR4+ T cells expressing relatively high levels of CD26C Callebaut, E Jacotot, J Blanco, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
The level of CD26 determines the rate of HIV entry in a CD4+ T-cell lineC Callebaut, E Jacotot, J Blanco, et al.
Virology|March 30, 2001
Inhibition of HIV infection by the cytokine midkineC Callebaut, S Nisole, J P Briand, et al.
Journal of Virology|April 25, 2000
CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcriptionS Le Borgne, M Février, C Callebaut, et al.
Pageof 3